Guangdong Huawei Biology Co., Ltd

Guangdong Huawei Biology Co., Ltd. established in 2021 and headquartered in Shenzhen, is a leading enterprise in China's innovative ecosystem chain of heparin. It is located in a country where the key development of the biopharmaceutical industry was explicitly outlined in the "Twelfth Five-Year Plan". The technical team of Huawei Biotechnology was initially established in 2016 and has been deeply involved in the heparin field for 7 years. Adhering to the principles of seeking innovation, excellence, and continuous improvement, Huawei continuously overcomes technical barriers in the heparin industry, allowing Huawei's intelligent manufacturing to spread worldwide. This contributes to the deep development of the global "heparin cause" and makes contributions to enhancing the quality and length of life for all mankind. Strategic Layout of Huawei's Ecological Industry Chain: By continuously exploring the ecological circular development system, Guangdong Huawei Biology Co., Ltd. empowers bio-technology innovation to "accelerate running" and provides "wings" for the high-quality development of the heparin industry. Through innovation, it promotes the upgrading of the bio-technology industry, shapes new advantages in bio-intelligence manufacturing development, and collaborates with colleagues in the biological industry to create a resilient, high-security, and continuously expanding bio-industry chain.